A 13-week comprehensive toxicity study with adductome analysis demonstrates the toxicity, genotoxicity, and carcinogenicity of the natural flavoring agent elemicin.


Journal

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
ISSN: 1873-6351
Titre abrégé: Food Chem Toxicol
Pays: England
ID NLM: 8207483

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 15 05 2023
revised: 10 07 2023
accepted: 23 07 2023
medline: 7 9 2023
pubmed: 27 7 2023
entrez: 26 7 2023
Statut: ppublish

Résumé

Elemicin, an alkenylbenzene flavoring, exists naturally in foods, herbs, and spices. Some alkenylbenzenes are hepatotoxic and hepatocarcinogenic in rodents. However, few studies have examined the toxicology of elemicin. In the current study, we comprehensively evaluated the general toxicity, genotoxicity, and carcinogenicity of elemicin using gpt delta rats and DNA adductome analysis. Groups of 10 male F344 gpt delta rats were treated with elemicin by gavage at a dose of 0, 25, 100, or 400 mg/kg bw/day for 13 weeks. Liver weights were significantly increased with histopathological changes in groups receiving 100 mg/kg bw/day or more. Significant increases in serum hepatotoxic parameters were observed in the 400 mg/kg bw/day group. Based on the observed changes in liver weights, 18.6 mg/kg bw was identified as the low benchmark dose. Significant increases in the number and area of glutathione S-transferase placental form-positive foci and gpt mutant frequencies were apparent only in the 400 mg/kg/day group, although elemicin-specific DNA adducts were detected from the lowest dose, suggesting that elemicin exhibited hepatocarcinogenicity in rats only at higher doses. Because elemicin showed no mutagenicity at lower doses, there was an adequate safety margin between the acceptable daily intake and the estimated daily intake of elemicin.

Identifiants

pubmed: 37495168
pii: S0278-6915(23)00367-8
doi: 10.1016/j.fct.2023.113965
pii:
doi:

Substances chimiques

Flavoring Agents 0
elemicin 487-11-6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

113965

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Yuji Ishii (Y)

Division of Pathology, National Institute of Health Sciences, Kanagawa, Japan.

Liang Shi (L)

Division of Pathology, National Institute of Health Sciences, Kanagawa, Japan.

Shinji Takasu (S)

Division of Pathology, National Institute of Health Sciences, Kanagawa, Japan.

Kumiko Ogawa (K)

Division of Pathology, National Institute of Health Sciences, Kanagawa, Japan.

Takashi Umemura (T)

Division of Pathology, National Institute of Health Sciences, Kanagawa, Japan; Graduate School of Animal Health Technology, Yamazaki University of Animal Health Technology, Tokyo, Japan. Electronic address: t_umemura@yamazaki.ac.jp.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH